← back to search

Thomas R. Cox

Garvan Institute of Medical Research ·
Area of research
Oncology · Management, Monitoring, Policy and Law
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, American Environmental and Regional History, Cancer Cells and Metastasis, and Cancer Genomics and Diagnostics.
h-index
49
citations
15,601
works
351
NIH funding
primary concept
email

Recent publications

Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics
Journal of Clinical Medicine 2025cited by 20position: middledoi
Photochemistry as a tool for dynamic modulation of hydrogel mechanics
Cell Reports Physical Science 2025cited by 12position: middledoi
Imaging Copper Levels during Life in the Brain and beyond Using a Fluorescent Copper Sensor with Multimodal Capacity
Chemical & Biomedical Imaging 2025cited by 7position: middledoi
Why do patients with cancer die?
Nature reviews. Cancer 2024cited by 115position: middledoi
Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid Metabolism
Advanced Science 2024cited by 23position: lastdoi
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis
Nature Communications 2022cited by 205position: lastdoi
Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma
Genome Medicine 2022cited by 85position: lastdoi
Stromal cell diversity associated with immune evasion in human triple‐negative breast cancer
The EMBO Journal 2020cited by 448position: middledoi
Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan
Frontiers in Oncology 2020cited by 176position: middledoi
The importance of developing therapies targeting the biological spectrum of metastatic disease
Clinical & Experimental Metastasis 2019cited by 13position: middledoi
Pre-metastatic niches: organ-specific homes for metastases
Nature reviews. Cancer 2017cited by 1,850position: middledoi
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis
Science Translational Medicine 2017cited by 266position: middledoi
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer
Gut 2017cited by 118position: middledoi
Meeting report: Metastasis Research Society–Chinese Tumor Metastasis Society joint conference on metastasis
Clinical & Experimental Metastasis 2017cited by 1position: middledoi
Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis
EMBO Reports 2015cited by 156position: middledoi
LOX-Mediated Collagen Crosslinking Is Responsible for Fibrosis-Enhanced Metastasis
Cancer Research 2013cited by 544position: firstdoi
LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
Breast Cancer Research 2013cited by 37position: middledoi
The rationale for targeting the LOX family in cancer
Nature reviews. Cancer 2012cited by 568position: middledoi

Grants

NSF East Asia and Pacific Summer Institute (EAPSI) for FY 2013 in China
NSF1316822$5,0702013–2014PIRePORTER

Frequent collaborators

Janine T. Erler · University of Copenhagen5 papers (2012–2017)Holly E. Barker · The University of Melbourne3 papers (2012–2013)Erik Sahai · The Francis Crick Institute3 papers (2015–2024)Yibin Kang · Rutgers, The State University of New Jersey2 papers (2017–2019)Barbara Fingleton · Vanderbilt University2 papers (2017–2019)Gretel S. Major · University of Canterbury2 papers (2020–2025) · 2 papers (2017–2019)Rosandra N. Kaplan · Center for Cancer Research2 papers (2017–2024)Maija R.J. Kohonen‐Corish · Garvan Institute of Medical Research1 papers (2022–2022)Elise D. Bowman · National Institutes of Health1 papers (2022–2022)Gonçalo Rodrigues · Sant Joan de Déu Research Foundation1 papers (2017–2017)Jacqueline Bromberg · Memorial Sloan Kettering Cancer Center1 papers (2017–2017)Dihua Yu · The University of Texas MD Anderson Cancer Center1 papers (2019–2019)Giselle C. Yeo · The University of Sydney1 papers (2025–2025)Ariana von Lersner · Florida State University1 papers (2019–2019)Ann‐Marie Baker · Institute of Cancer Research1 papers (2013–2013)Chris D. Madsen · Lund University1 papers (2015–2015)Guillaume Charras · London Centre for Nanotechnology1 papers (2015–2015)David Lyden · Cornell University1 papers (2017–2017) · 1 papers (2015–2015)